The American College of Medical Genetics and Genomics (ACMG) provides recommendations for reporting incidental findings in clinical exome and genome sequencing. The policy emphasizes the importance of alerting patients to the possibility of incidental findings during pretest discussions and outlines the responsibilities of laboratories and clinicians in managing these findings. The document includes a minimum list of conditions, genes, and variants that should be reported as incidental findings, regardless of the patient's age. The recommendations aim to balance patient autonomy with the potential medical benefits of reporting incidental findings.
documents/EFTA00287263.pdf
{}